Asensus Surgical Inc
F:2TX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Asensus Surgical Inc
Other Long-Term Assets
Asensus Surgical Inc
Other Long-Term Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Long-Term Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Asensus Surgical Inc
F:2TX
|
Other Long-Term Assets
$6.9m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
54%
|
CAGR 10-Years
33%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Other Long-Term Assets
$5.1B
|
CAGR 3-Years
3%
|
CAGR 5-Years
1%
|
CAGR 10-Years
26%
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Other Long-Term Assets
$1.9B
|
CAGR 3-Years
34%
|
CAGR 5-Years
40%
|
CAGR 10-Years
20%
|
|
|
Stryker Corp
NYSE:SYK
|
Other Long-Term Assets
$3.7B
|
CAGR 3-Years
3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
12%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Other Long-Term Assets
$18.4B
|
CAGR 3-Years
42%
|
CAGR 5-Years
38%
|
CAGR 10-Years
22%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Other Long-Term Assets
$1.7B
|
CAGR 3-Years
11%
|
CAGR 5-Years
16%
|
CAGR 10-Years
26%
|
|
Asensus Surgical Inc
Glance View
Asensus Surgical, Inc. is a medical device company, which digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. The company is headquartered in Durham, North Carolina and currently employs 183 full-time employees. The firm is engaged in digitizing the interface between the surgeon and patient to reimagine surgery through Performance-Guided Surgery (PGS), by unlocking clinical intelligence to enable surgeons to deliver consistently superior outcomes to patients and establish a new standard of surgery. The firm is focused on the market development for and commercialization of the Senhance Surgical System, which digitizes laparoscopic minimally invasive surgery (MIS). The Senhance System is a digital, multi-port laparoscopic platform designed to maintain laparoscopic MIS standards while providing digital benefits such as haptic feedback, robotic precision, comfortable ergonomics, advanced instrumentation including 3 millimeters (mm) micro-laparoscopic instruments, 5mm articulating instruments, eye-sensing camera control and fully-reusable standard instruments to help maintain per-procedure costs similar to traditional laparoscopy.
See Also
What is Asensus Surgical Inc's Other Long-Term Assets?
Other Long-Term Assets
6.9m
USD
Based on the financial report for Mar 31, 2024, Asensus Surgical Inc's Other Long-Term Assets amounts to 6.9m USD.
What is Asensus Surgical Inc's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 10Y
33%
Over the last year, the Other Long-Term Assets growth was -22%. The average annual Other Long-Term Assets growth rates for Asensus Surgical Inc have been -9% over the past three years , 54% over the past five years , and 33% over the past ten years .